This is an academic paper that provides results of a qualitative study that interviewed buprenorphine prescribers on how they have adapted to the coronavirus pandemic. Most providers were only doing telehealth visits. Noted positives included increased access to treatment and noted negatives included technological issues and less structure and accountability.